Barcelona, May 2026 – The Mediterranean breeze swept across the venue of Vitafoods Europe 2026 in Barcelona. This global health industry landmark event, spanning 135 countries and featuring over 1,600 exhibitors, welcomed the debut of China’s leading probiotics company, UNISONS.

With its self-developed flagship strains, breakthrough inactivation technologies, and latest blended powder solutions, UNISONS presented a comprehensive “UNISONS Intelligent Manufacturing” showcase. From strain development to industrial application, from clinical evidence to dosage form innovation, Yuansheng Biotech is redefining the global probiotics supply chain with the depth and rigor of “China’s microbial expertise.”

01. AMY001 – New Akkermansia Strain

High-Purity Inactivation Unlocks New Opportunities in Weight Management and Metabolic Health

If there was a “golden track” at this year’s event, it was undoubtedly weight management & metabolic health. UNISONS strategically entered this hot spot by presenting for the first time in Europe its flagship postbiotic: Unisons® Akkermansia muciniphila AMY001, targeting gut barrier health.

Purity & Safety: Isolated from healthy adult intestines, AMY001 achieves a metagenomic purity of 99.84% after pasteurization inactivation, with zero detection of strict anaerobes or facultative anaerobes.

Functional Preservation: UNISONS’ low-temperature inactivation process preserves bacterial protein activity. AKK antibody-binding assays show a binding rate of 43.37% in the inactivated powder, comparable to 38.98% in live bacteria, solving the industry challenge that inactivation often leads to functional loss.

Preclinical Evidence: In high-fat diet models, inactivated AMY001 inhibited weight gain, reduced visceral fat, improved lipid profiles, decreased fasting blood glucose by 21.16%, and increased GLP-1 by 12.65%, demonstrating multifunctional potential in regulating glucose and lipid metabolism.

Patented and fully compliant with EU Novel Food Regulations, AMY001 provides a regulatory-compliant, functionally stable postbiotic solution for weight management and metabolic health. Its compatibility with gummies, beverages, and other dosage forms made it one of the most inquired-about strains at the exhibition.

02. Bb-12 & GG – The Classic Twin Strains

Stability as the Foundation of Global Application Confidence

If AMY001 was the “rising star” of the booth, Bifidobacterium animalis subsp. lactis Bb-12 and Lactobacillus rhamnosus GG (LGG) are UNISONS’ “classic twin stars”, representing a cornerstone of trust for the global market.

Proven Track Record: Decades of global research accumulation have cemented Bb-12 and GG as benchmarks in gut health and immune support.

Differentiated Stability: Accelerated stability tests at 37°C demonstrate robust survival under standard and harsh storage conditions.

High-Activity Blends: UNISONS’ Probiotic Blends BG (Bb-12 + GG) and BA (Bb-12 + Lacticaseibacillus acidophilus QS008) achieve 100 billion CFU/g, ensuring “high activity and long shelf life” for capsules, powders, drops, and dairy products.

03. 1,000+ Blended Powder Solutions

One-Stop Delivery for Cost-Effective Global Probiotic Products

At the exhibition, UNISONS showcased its 1,000+ mature blended powder formulations, covering gut health, immune support, women’s health, and more.

Women’s Health Focus: Two female-focused blends, QSNX-001 and QSNX-002, achieved 100 billion CFU/g, with QSNX-002 showing superior antibacterial efficacy, providing a ready-to-use blueprint for women’s microecological supplements.

Flexible Dosage Forms: The concentrated Unisons Probiotic Drops (“one drop equals ten”) drew significant attention. Through flexible combinations of blended powders and dosage forms, UNISONS offers one-stop ODM/CDMO services, from formulation design and pilot-scale scale-up to industrial filling, achieving quality-cost optimization for global brands.

Connecting the World Through Microbes

From AMY001’s targeted approach to weight management, to Bb-12 & GG’s continued foundation in gut immunity, and to the empowerment of over 1,000 blended powder formulations, UNISONS presented a three-dimensional showcase at Vitafoods Europe 2026:

Evidence-based R&D × Intelligent Manufacturing × Flexible Delivery

By making high-quality probiotics globally accessible, UNISONS demonstrates the craftsmanship, dedication, and resilience of China’s probiotic industry, letting the world witness the hardcore strength of Chinese microbial innovation.